Background/Aim: The two-way cause and effect relationship existing between high blood pressure and kidney dysfunction is currently a well-documented phenomenon with patients in either category being almost equally predisposed to the other pathology. Our goal was to assess the renal function capacity of hypertensive patients in our setting. Methods: This cross-sectional descriptive study involved the determination of blood pressure levels and the collection of blood and urine samples for the measurement of renal function markers. Hypertensive patients who came for medical follow-up constituted the study participants, and were enrolled consecutively into the study from February to May 2015. Data analysis was performed using the SPSS 20.0 software, and significant differences were determined at p < 0.05. Results: The prevalence of elevated creatinine and urea levels were 35 and 27%. Eighty percent of the participants had a decreased glomerular filtration rate (≤90 mL/min/1.73 m3), with at least 36% recording less than 60 mL/min/1.73 m3. Proteinuria and glucosuria were recorded in 15% and 8% of the participants, respectively. The mean diastolic pressure was observed to be significantly higher in participants with proteinuria (p = 0.016), and participants' weight directly correlated with systolic blood pressure (p = 0.015). Furthermore, the mean estimated glomerular filtration rate was relatively lower in participants >60 years compared to those <60 years (p < 0.001). Conclusion: Renal function is often perturbed in hypertensive patients, and good blood pressure control may reduce the progression of renal impairment. Thus, a systematic evaluation of renal function in addition to blood pressure control in hypertensive patients is indispensable towards effectively reducing the occurrence of renal events and preventing end-stage renal disease.

Keywords:
Essential hypertension, Blood pressure, Kidney function, Creatinine, Glomerular filtration rate, Urine chemistry
1.
Tedgui A: Hypertension artérielle, Institut national de la santé et de la recherche médicale (Inserm), Centre de recherche Cardiovasculaire (PARCC). 2014.
2.
United States Renal Data System. USRDS 2007 Annual Data Report. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, U.S. Department of Health and Human Services. 2007.
3.
Opie LH, Seedat YK: Hypertension in sub-Saharan African populations. Circulation 2005;6:112:3562-3568.
4.
Mbanya JC, Minkoulou EM, Salah JN, Balkau B: The prevalence of hypertension in rural and urban Cameroon. Int J Epidemiol 1998;27:181-185.
5.
Cruickshank JK, Mbanya JC, Wilks R, Balkau B, Forrester T, Anderson SG, et al: Hypertension in four African-origin populations: current “Rule of Halves,” quality of blood pressure control and attributable risk of cardiovascular disease. J Hypertens 2001;19:41-46.
6.
Sobngwi E, Mbanya JC, Unwin NC, Porcher R, Kengne AP, Fezeu L, et al: Exposure over the life course to an urban environment and its relation with obesity, diabetes, and hypertension in rural and urban Cameroon. Int J Epidemiol 2004;33:769-776.
7.
Bygbjerg IC: Double burden of noncommunicable and infectious diseases in developing countries. Science 2012;337:1499-1501.
8.
de Ramirez SS, Enquobahrie DA, Nyadzi G, Mjungu D, Magombo F, Ramirez M, et al: Prevalence and correlates of hypertension: a cross-sectional study among rural populations in sub-Saharan Africa. J Hum Hypertens 2010;2:786-795.
9.
Schlaich MP, Sobotka PA, Krum H, Lambert EA, Esler MD: Renal sympathetic nerve ablation for the treatment of uncontrolled hypertension. N Engl J Med 2009;361:932-934.
10.
Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
11.
Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-470.
12.
Levey AS, Greene T, Kusek JW, Beck GJ, Group MS: A simplified equation to predict glomerular filtration rate from serum creatinine [Abstract]. J Am Soc Nephrol 2000;11:A0828.
13.
KDIGO: KDIGO 2012 Clinical practice guidelines for the evaluation and management of chronic kidney disease. Kidney Int Suppl 2013;3:136-150.
14.
Kannapiran M, Nisha D, Rao MA: Underestimation of impaired kidney function with serum creatinine. Indian J Clin Biochem 2010;25:380-384.
15.
Duncan L, Heathcote J, Djurdjev O, Levin A: Screening for renal disease using serum creatinine: who are we missing? Nephrol Dial Transplant 2001;16:1042-1046.
16.
Singh NP, Ingle GK, Saini VK, Jamil A, Beniwal P, Lal M, et al: Prevalence of low glomerular filtration rate proteinuria and associated risk factors in North India using Cockcroft-Gault and modification of diet in renal disease equation: an observational, cross-sectional study. BMC Nephrol 2009;10:1-13.
17.
Shemesh O, Golbetz H, Kriss JP, Myers BD: Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int 1985;28:830-838.
18.
Perrone RD, Madias NE, Levey AS: Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem 1992;38:1933-1953.
19.
Stevens LA, Coresh J, Feldman HI, Greene T, Lash JP, Nelson RG, et al: Evaluation of the modification of diet in renal disease study equation in a large diverse population. J Am Soc Nephrol 2007;18:2749-2757.
20.
Addo J, Smeeth L, Leon DA: Hypertensive target organ damage in Ghanaian civil servants with hypertension. PLoS One 2009;4:e6672.
21.
Gansevoort RT, de Jong PE: Challenges for the present CKD classification system. Curr Opin Nephrol Hypertens 2010;19:308-314.
22.
Bidani AK, Griffin KA: Chronic kidney disease: Blood-pressure targets in chronic kidney disease. Nat Rev Nephrol 2011;7:128-130.
23.
Yan P, Zhu X, Li H, Shrubsole MJ, Shi H, Zhang MZ, et al: Association of high blood pressure with renal insufficiency: role of albuminuria, from NHANES, 1999-2006. PLoS One 2012;7:e37837.
24.
Grabysa R, Cholewa M: Diminished glomerular filtration rate as a marker of chronic kidney disease in hypertensive patients. Pol Merkur Lekarski 2008;24:487-491.
25.
Hall ME, do Carmo JM, da Silva AA, Juncos LA, Wang Z, Hall JE: Obesity, hypertension, and chronic kidney disease. Int J Nephrol Renovasc Dis 2014;7:75-88.
26.
Hendriks M, Brewster L, Wit F, Bolarinwa O, Odusola, AO, Redekop W, et al: Cardiovascular disease prevention in rural Nigeria in the context of a community based health insurance scheme: quality improvement cardiovascular care Kwara-I (QUICK-I). BMC Public Health 2011;11:186.
27.
Pancha OM, Yiagnigni E, Koona AK, Cacko J, Ndobo P: Determinants of hypertension awareness and treatment among patients under cardiology follow-up in a Cameroonian regional hospital. Int J Collab Res Intern Med Public Health 2012;4:1666-1667.
28.
Richards AM, Nicholls MG, Espiner EA, Ikram H, Yandle TG, Joyce SL, Cullens MM: Effects of alpha-human atrial natriuretic peptide in essential hypertension Hypertension 1985;7:812-817.
29.
Kiberd BA, Larson TS, Robertson CR, Jamison RL: Effect of atrial natriuretic peptide on vasa recta blood flow in the rat. Am J Physiol 1987;252:F1112-F1117.
30.
Reeves WB, Andreoli TE: Chapter 31 - Sodium chloride transport in the loop of Henle, distal convoluted tubule, and collecting duct; in Giebisch GH, Alpern RA, Herbert SC, Seldin DW (eds): Seldin and Giebisch's the Kidney: Physiology and Pathophysiology. Amsterdam, Elsevier/Academic Press, 2008.
31.
Ahmed F, Tabassum N, Rasool S: Regulation of atrial natriuretic peptide (ANP) and its role in blood pressure. Int Curr Pharm J 2012;1:176-179.
32.
Fazekas AS, Funk GC, Klobassa DS, Rüther H, Ziegler I, Zander R, Semmelrock HJ: Evaluation of 36 formulas for calculating plasma osmolality. Intensive Care Med 2013;39:302-308.
33.
Siervo M, Bunn D, Prado CM, Hooper L: Accuracy of prediction equations for serum osmolarity in frail older people with and without diabetes. Am J Clin Nutr 2014;100:867-876.
34.
Hooper L, Abdelhamid A, Ali A, Bunn DK, Jennings A, John WG, Kerry S, Lindner G, Pfortmueller CA, Sjöstrand F, Walsh NP, Fairweather-Tait SJ, Potter JF, Hunter PR, Shepstone L: Diagnostic accuracy of calculated serum osmolarity to predict dehydration in older people: adding value to pathology laboratory reports. BMJ Open 2015;5:e008846.
35.
Ofori SN, Odia OJ: Serum uric acid and target organ damage in essential hypertension. Vasc Health Risk Manag 2014;10:253-261.
36.
Ruilope LM, Salvetti A, Jamerson K, Hansson L, Warnold I, Wedel H, Zanchetti A: Renal function and intensive lowering of blood pressure in hypertensive participants of the Hypertension Optimal Treatment (HOT) Study. J Am Soc Nephrol 2001;12:218-225.
37.
Kurata A, Shigematsu Y, Higaki J: Sex-related differences in relations of uric acid to left ventricular hypertrophy and remodeling in Japanese hypertensive patients. Hypertens Res 2005;28:133-139.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.